...
首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >Factor Xa-driven thrombin generation in plasma: dependency on the aminophospholipid density of membranes and inhibition by phospholipid-binding proteins.
【24h】

Factor Xa-driven thrombin generation in plasma: dependency on the aminophospholipid density of membranes and inhibition by phospholipid-binding proteins.

机译:血浆中Xa因子驱动的凝血酶生成:依赖于膜的氨基磷脂密度和磷脂结合蛋白的抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Phosphatidylserine (PS) externalization of activated platelets plays a pivotal role in haemostasis and thrombosis. In the present study we have explored the relationship between the PS density of membranes and the rate of thrombin generation in plasma. Factor (F)Xa-initiated thrombin generation was measured in platelet-free plasma (PFP) containing either phospholipid vesicles of varying PS-content or non-stimulated platelets (reconstituted PRP). The duration of the initiation phase of FXa-driven thrombin generation decreased dramatically with increasing PS density. Concomitantly, the maximal rate of thrombin generation during the propagation phase (maxR) increased non-linearly, with the steepest incline between 5 and 10 mol% PS. Titration of FVa into plasma containing 2 mol% PS increased maxR proportionally and diminished the lag phase. In contrast, platelet-dependent thrombin generation was not influenced by addition of FVa. With increasing platelet concentration, the duration of the initiation phase drastically decreased, and maxR increased proportionally. At a physiologically relevant platelet concentration, maxR corresponded with the maxR found with 2 microM of 10 mol% PS. Annexin A5 (AnxA5) and lactadherin appeared to be powerful inhibitors of in-situ thrombin generation under all conditions examined, with AnxA5 being three- to four-fold more potent than lactadherin. In conclusion, maximal thrombin generation in plasma requires membranes with a density of 10-20 mol% PS. Our data further indicate that thrombin formed in situ induces externalization of PS to approx 10 mol% in a substantial platelet subpopulation.
机译:活化血小板的磷脂酰丝氨酸(PS)外部化在止血和血栓形成中起关键作用。在本研究中,我们探索了膜的PS密度与血浆中凝血酶生成速率之间的关系。在无血小板血浆(PFP)中测量因子(F)Xa引发的凝血酶生成,该血浆中含有不同PS含量的磷脂囊泡或未刺激的血小板(重构的PRP)。 FXa驱动的凝血酶生成起始阶段的持续时间随着PS密度的增加而显着减少。随之而来的是,在传播阶段,最大的凝血酶生成速率(maxR)呈非线性增长,最陡的斜率在5至10 mol%PS之间。将FVa滴定到含有2 mol%PS的血浆中会成比例地增加maxR并减少滞后阶段。相反,血小板依赖性凝血酶的产生不受FVa添加的影响。随着血小板浓度的增加,起始阶段的持续时间急剧减少,并且maxR成比例增加。在生理相关的血小板浓度下,maxR对应于2 microM的10 mol%PS中发现的maxR。在所有检查的条件下,膜联蛋白A5(AnxA5)和乳黏附素似乎是原位凝血酶生成的强大抑制剂,AnxA5的效力比乳黏附素高三到四倍。总之,血浆中凝血酶的最大产生需要膜的PS密度为10-20 mol%。我们的数据进一步表明,在大量血小板亚群中,原位形成的凝血酶可诱导PS外部化至约10 mol%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号